Global Long-acting Injectable Medications Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Market Analysis by Type
  • 1.3.1 Global Long-acting Injectable Medications Market Size Growth Rate by Type: 2020 VS 2026
  • 1.3.2 First-generation
  • 1.3.3 Second-generation
• 1.4 Market by Application
  • 1.4.1 Global Long-acting Injectable Medications Market Share by Application: 2020 VS 2026
  • 1.4.2 Schizophrenia
  • 1.4.3 Contraception
  • 1.4.4 HIV
  • 1.4.5 Others
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Long-acting Injectable Medications Market Perspective (2015-2026)
• 2.2 Long-acting Injectable Medications Growth Trends by Regions
  • 2.2.1 Long-acting Injectable Medications Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Long-acting Injectable Medications Historic Market Share by Regions (2015-2020)
  • 2.2.3 Long-acting Injectable Medications Forecasted Market Size by Regions (2021-2026)
• 2.3 Long-acting Injectable Medications Industry Dynamic
  • 2.3.1 Long-acting Injectable Medications Market Trends
  • 2.3.2 Long-acting Injectable Medications Market Drivers
  • 2.3.3 Long-acting Injectable Medications Market Challenges
  • 2.3.4 Long-acting Injectable Medications Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Long-acting Injectable Medications Players by Market Size
  • 3.1.1 Global Top Long-acting Injectable Medications Players by Revenue (2015-2020)
  • 3.1.2 Global Long-acting Injectable Medications Revenue Market Share by Players (2015-2020)
• 3.2 Global Long-acting Injectable Medications Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Long-acting Injectable Medications Revenue
• 3.4 Global Long-acting Injectable Medications Market Concentration Ratio
  • 3.4.1 Global Long-acting Injectable Medications Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Long-acting Injectable Medications Revenue in 2019
• 3.5 Key Players Long-acting Injectable Medications Area Served
• 3.6 Key Players Long-acting Injectable Medications Product Solution and Service
• 3.7 Date of Enter into Long-acting Injectable Medications Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Long-acting Injectable Medications Breakdown Data by Type

• 4.1 Global Long-acting Injectable Medications Historic Market Size by Type (2015-2020)
• 4.2 Global Long-acting Injectable Medications Forecasted Market Size by Type (2021-2026)

5 Long-acting Injectable Medications Breakdown Data by Application

• 5.1 Global Long-acting Injectable Medications Historic Market Size by Application (2015-2020)
• 5.2 Global Long-acting Injectable Medications Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Long-acting Injectable Medications Market Size (2015-2026)
• 6.2 North America Long-acting Injectable Medications Market Size by Type (2015-2020)
• 6.3 North America Long-acting Injectable Medications Market Size by Application (2015-2020)
• 6.4 North America Long-acting Injectable Medications Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Long-acting Injectable Medications Market Size (2015-2026)
• 7.2 Europe Long-acting Injectable Medications Market Size by Type (2015-2020)
• 7.3 Europe Long-acting Injectable Medications Market Size by Application (2015-2020)
• 7.4 Europe Long-acting Injectable Medications Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic

8 Asia-Pacific

• 8.1 Asia-Pacific Long-acting Injectable Medications Market Size (2015-2026)
• 8.2 Asia-Pacific Long-acting Injectable Medications Market Size by Type (2015-2020)
• 8.3 Asia-Pacific Long-acting Injectable Medications Market Size by Application (2015-2020)
• 8.4 Asia-Pacific Long-acting Injectable Medications Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia

9 Latin America

• 9.1 Latin America Long-acting Injectable Medications Market Size (2015-2026)
• 9.2 Latin America Long-acting Injectable Medications Market Size by Type (2015-2020)
• 9.3 Latin America Long-acting Injectable Medications Market Size by Application (2015-2020)
• 9.4 Latin America Long-acting Injectable Medications Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Long-acting Injectable Medications Market Size (2015-2026)
• 10.2 Middle East & Africa Long-acting Injectable Medications Market Size by Type (2015-2020)
• 10.3 Middle East & Africa Long-acting Injectable Medications Market Size by Application (2015-2020)
• 10.4 Middle East & Africa Long-acting Injectable Medications Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE

11Key Players Profiles

• 11.1 Eli Lilly
  • 11.1.1 Eli Lilly Company Details
  • 11.1.2 Eli Lilly Business Overview
  • 11.1.3 Eli Lilly Long-acting Injectable Medications Introduction
  • 11.1.4 Eli Lilly Revenue in Long-acting Injectable Medications Business (2015-2020))
  • 11.1.5 Eli Lilly Recent Development
• 11.2 Alkermes
  • 11.2.1 Alkermes Company Details
  • 11.2.2 Alkermes Business Overview
  • 11.2.3 Alkermes Long-acting Injectable Medications Introduction
  • 11.2.4 Alkermes Revenue in Long-acting Injectable Medications Business (2015-2020)
  • 11.2.5 Alkermes Recent Development
• 11.3 Johnson & Johnson
  • 11.3.1 Johnson & Johnson Company Details
  • 11.3.2 Johnson & Johnson Business Overview
  • 11.3.3 Johnson & Johnson Long-acting Injectable Medications Introduction
  • 11.3.4 Johnson & Johnson Revenue in Long-acting Injectable Medications Business (2015-2020)
  • 11.3.5 Johnson & Johnson Recent Development
• 11.4 Zogenix
  • 11.4.1 Zogenix Company Details
  • 11.4.2 Zogenix Business Overview
  • 11.4.3 Zogenix Long-acting Injectable Medications Introduction
  • 11.4.4 Zogenix Revenue in Long-acting Injectable Medications Business (2015-2020)
  • 11.4.5 Zogenix Recent Development
• 11.5 DURECT
  • 11.5.1 DURECT Company Details
  • 11.5.2 DURECT Business Overview
  • 11.5.3 DURECT Long-acting Injectable Medications Introduction
  • 11.5.4 DURECT Revenue in Long-acting Injectable Medications Business (2015-2020)
  • 11.5.5 DURECT Recent Development
• 11.6 Mapi Pharma
  • 11.6.1 Mapi Pharma Company Details
  • 11.6.2 Mapi Pharma Business Overview
  • 11.6.3 Mapi Pharma Long-acting Injectable Medications Introduction
  • 11.6.4 Mapi Pharma Revenue in Long-acting Injectable Medications Business (2015-2020)
  • 11.6.5 Mapi Pharma Recent Development
• 11.7 GSK
  • 11.7.1 GSK Company Details
  • 11.7.2 GSK Business Overview
  • 11.7.3 GSK Long-acting Injectable Medications Introduction
  • 11.7.4 GSK Revenue in Long-acting Injectable Medications Business (2015-2020)
  • 11.7.5 GSK Recent Development
• 11.8 MedinCell
  • 11.8.1 MedinCell Company Details
  • 11.8.2 MedinCell Business Overview
  • 11.8.3 MedinCell Long-acting Injectable Medications Introduction
  • 11.8.4 MedinCell Revenue in Long-acting Injectable Medications Business (2015-2020)
  • 11.8.5 MedinCell Recent Development
• 11.9 Oakwood Labs
  • 11.9.1 Oakwood Labs Company Details
  • 11.9.2 Oakwood Labs Business Overview
  • 11.9.3 Oakwood Labs Long-acting Injectable Medications Introduction
  • 11.9.4 Oakwood Labs Revenue in Long-acting Injectable Medications Business (2015-2020)
  • 11.9.5 Oakwood Labs Recent Development
• 11.10 Nanomi
  • 11.10.1 Nanomi Company Details
  • 11.10.2 Nanomi Business Overview
  • 11.10.3 Nanomi Long-acting Injectable Medications Introduction
  • 11.10.4 Nanomi Revenue in Long-acting Injectable Medications Business (2015-2020)
  • 11.10.5 Nanomi Recent Development
• 11.11 Pharmathen
  • 10.11.1 Pharmathen Company Details
  • 10.11.2 Pharmathen Business Overview
  • 10.11.3 Pharmathen Long-acting Injectable Medications Introduction
  • 10.11.4 Pharmathen Revenue in Long-acting Injectable Medications Business (2015-2020)
  • 10.11.5 Pharmathen Recent Development
• 11.12 Kashiv BioSciences
  • 10.12.1 Kashiv BioSciences Company Details
  • 10.12.2 Kashiv BioSciences Business Overview
  • 10.12.3 Kashiv BioSciences Long-acting Injectable Medications Introduction
  • 10.12.4 Kashiv BioSciences Revenue in Long-acting Injectable Medications Business (2015-2020)
  • 10.12.5 Kashiv BioSciences Recent Development

12Analyst's Viewpoints/Conclusions

13Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer